Correlation Between PTC Therapeutics and Mersana Therapeutics
Can any of the company-specific risk be diversified away by investing in both PTC Therapeutics and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PTC Therapeutics and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PTC Therapeutics and Mersana Therapeutics, you can compare the effects of market volatilities on PTC Therapeutics and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PTC Therapeutics with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PTC Therapeutics and Mersana Therapeutics.
Diversification Opportunities for PTC Therapeutics and Mersana Therapeutics
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between PTC and Mersana is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding PTC Therapeutics and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and PTC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PTC Therapeutics are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of PTC Therapeutics i.e., PTC Therapeutics and Mersana Therapeutics go up and down completely randomly.
Pair Corralation between PTC Therapeutics and Mersana Therapeutics
Given the investment horizon of 90 days PTC Therapeutics is expected to generate 1.97 times less return on investment than Mersana Therapeutics. But when comparing it to its historical volatility, PTC Therapeutics is 2.53 times less risky than Mersana Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Mersana Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 187.00 in Mersana Therapeutics on August 31, 2024 and sell it today you would earn a total of 32.00 from holding Mersana Therapeutics or generate 17.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
PTC Therapeutics vs. Mersana Therapeutics
Performance |
| Timeline |
| PTC Therapeutics |
| Mersana Therapeutics |
PTC Therapeutics and Mersana Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PTC Therapeutics and Mersana Therapeutics
The main advantage of trading using opposite PTC Therapeutics and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PTC Therapeutics position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.| PTC Therapeutics vs. Krystal Biotech | PTC Therapeutics vs. Sarepta Therapeutics | PTC Therapeutics vs. Iovance Biotherapeutics | PTC Therapeutics vs. Madrigal Pharmaceuticals |
| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |